| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| ancrod | fibrinogen alpha chain | biotech | NA | drugbank | Hypertensive disease[MeSHID:D006973] Insertion Mutation[MeSHID:D016254] Deep Vein Thrombosis[MeSHID:D020246] Femoral Neck Fractures[MeSHID:D005265] Retinal Vein Occlusion[MeSHID:D012170] Embolism[MeSHID:D004617] Pulmonary Embolism[MeSHID:D011655] Wound Healing[MeSHID:D014945] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Hematological Disease[MeSHID:D006402] |
NA | approved,investigational | unknown |
| ancrod | vitamin k-dependent protein c | NA | Successful target | TTD , DGIDB | Hypertensive disease[MeSHID:D006973] Insertion Mutation[MeSHID:D016254] Deep Vein Thrombosis[MeSHID:D020246] Femoral Neck Fractures[MeSHID:D005265] Retinal Vein Occlusion[MeSHID:D012170] Embolism[MeSHID:D004617] Pulmonary Embolism[MeSHID:D011655] Wound Healing[MeSHID:D014945] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Hematological Disease[MeSHID:D006402] |
7.96 | phase 3 | unknown |
| click here to return to the previous page | ||||||||